Transcriptomics

Dataset Information

0

Regulation of DNA Methylation at Enhancers by TET2 Finetunes Gene Transcription in ERα-Positive Breast Cancer Cells


ABSTRACT: Background: Aberrant DNA methylation is an epigenetic hallmark of most malignant tumors including breast cancer. However, the exact role of TET2-mediated DNA demethylation in ERα-positive luminal breast cancer is not well understood. Results: Here we showed by TCGA analyses that lower TET2 mRNA expression level is associated with worse clinical outcomes (i.e., overall survival) in ERα-positive but not ERα-negative breast cancer. Moreover, depletion of TET2 by CRISPR/Cas9 results in increased tumorigenesis capability of MCF7 cells in vitro. Whole genome bisulfite sequencing (WGBS) analysis revealed that DNA hypermethylation (gain-of-5mC) occurs within a subgroup of enhancers including estrogen responsive element (EREs) in MCF7 cells upon TET2 depletion. ChIP-seq and RNA-seq analysis showed that TET2 depletion impairs E2-induced ERα binding to these ‘gain-of-5mC’ EREs and gene transcription. Conclusions: Our data suggest that TET2-mediated enhancer DNA demethylation fine-tunes ERα-dependent and independent gene transcription in ERα-positive breast cancer cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE136673 | GEO | 2020/07/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-11-28 | GSE189507 | GEO
2021-02-10 | PXD019438 | Pride
2014-07-10 | E-GEOD-55921 | biostudies-arrayexpress
2022-10-19 | GSE186645 | GEO
2022-10-19 | GSE186644 | GEO
2022-10-19 | GSE186643 | GEO
2013-11-21 | GSE45047 | GEO
2014-03-03 | E-GEOD-53532 | biostudies-arrayexpress
2020-09-02 | PXD018709 | Pride
2010-09-01 | E-GEOD-20361 | biostudies-arrayexpress